Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Roche reports 1H13 sales of new cancer drugs

Roche (SIX:ROG; OTCQX:RHHBY) reported 1H13 earnings on Thursday, including sales for its two newest drugs for HER2-positive metastatic breast cancer. The pharma recorded

Read the full 232 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE